CRDF · Cardiff Oncology, Inc. · Debt
$0.91
-0.02 (-2.23%)
At close · Oct 23
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management has performed an analysis and concluded that there exists a substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 11, 2026
Market Cap
$70.58M
Shares
77.80M
Volume · Oct 23
174.71K
Avg daily vol (3M)
717.67K
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current operating lease liabilities | 2026-06-30 | USD 457,000 | 10-Q filed 2026-08-11 |
| Noncurrent operating lease liabilities | 2026-06-30 | USD 0 | 10-Q filed 2026-08-11 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
1213037
CUSIP
14147L108
13F (30d)
12 filings
12 filers
Visit website
Investor relations